Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study-Reference-Cited by-同舟云学术

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

Published:2015-03-27 Issue:8 Volume:11 Page:964-974
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Sabri Osama¹,Sabbagh Marwan N.²,Seibyl John³,Barthel Henryk¹,Akatsu Hiroyasu⁴⁵⁶,Ouchi Yasuomi⁷,Senda Kohei⁸,Murayama Shigeo⁹¹⁰,Ishii Kenji¹⁰,Takao Masaki¹⁰¹¹,Beach Thomas G.²,Rowe Christopher C.¹²,Leverenz James B.¹³,Ghetti Bernardino¹⁴,Ironside James W.¹⁵,Catafau Ana M.¹⁶,Stephens Andrew W.¹⁶,Mueller Andre¹⁶,Koglin Norman¹⁶,Hoffmann Anja¹⁷,Roth Katrin¹⁷,Reininger Cornelia¹⁷,Schulz‐Schaeffer Walter J.¹⁸,

Affiliation:

1. Department of Nuclear Medicine University of Leipzig Leipzig Germany

2. Banner Sun Health Research Institute Sun City AZ USA

3. Molecular Neuroimaging LLC New Haven CT USA

4. Fukushimura Hospital Toyohashi Japan

5. Department of Community‐based Medicine Nagoya City University Graduate School of Medical Sciences Nagoya City Aichi Japan

6. Department of Neurology Nagoya City University Graduate School of Medical Sciences Nagoya City Aichi Japan

7. Department of Biofunctional Imaging Medical Photonics Research Center Hamamatsu University School of Medicine Hamamatsu Japan

8. Koseikai Hospital Toyohashi Japan

9. Department of Neurology and Neuropathology Tokyo Metropolitan Geriatric Hospital & Institute of Gerontology Tokyo Japan

10. Tokyo Metropolitan Institute of Gerontology Tokyo Japan

11. Mihara Memorial Hospital Isesaki Japan

12. Department of Molecular Imaging, Austin Health University of Melbourne Melbourne VIC Australia

13. VA‐Puget Sound Health Care System and University of Washington Seattle WA USA

14. Department of Pathology and Laboratory Medicine Indiana University School of Medicine Indianapolis IN USA

15. Centre for Clinical Brain Sciences University of Edinburgh Edinburgh Scotland

16. Piramal Imaging GmbH Berlin Germany

17. Bayer Pharma AG Berlin Germany

18. Department of Neuropathology University Medical Center Göttingen Göttingen Germany

Funder

Bioscript Medical

Piramal Imaging S.A

Bayer Pharma AG

Piramal Imaging S.A.

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2015.02.004

Reference31 articles.

1. Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease

2. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

3. Revising the definition of Alzheimer's disease: a new lexicon

4. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

5. Alzheimer Disease: New Concepts on Its Neurobiology and the Clinical Role Imaging Will Play

Cited by 393 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simple Synthesis of [18F] AV-45 and its Clinical Application in the Diagnosis of Alzheimer's Disease;Current Medicinal Chemistry;2024-03

2. Dopamine transporter positron emission tomography in patients with Alzheimer’s disease with Lewy body disease features;Neurobiology of Aging;2024-02

3. Elevated Amyloid-β PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology;Journal of Alzheimer's Disease;2024-01-30

4. Extensive Frontal Focused Ultrasound-Mediated Blood-Brain Barrier Opening for the Treatment of Alzheimer’s Disease: An Open-Label Prospective Study;2024-01-10

5. Liquid–liquid phase separation in Alzheimer’s disease;Journal of Molecular Medicine;2024-01-02